Accretion Nutraveda Limited (BOM:544694)

India flag India · Delayed Price · Currency is INR
268.90
+43.90 (19.51%)
At close: Apr 28, 2026
Market Cap 1.95B
Revenue (ttm) 160.49M
Net Income (ttm) 26.13M
Shares Out 7.24M
EPS (ttm) 7.19
PE Ratio 37.40
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 141,000
Average Volume 18,000
Open 216.00
Previous Close 225.00
Day's Range 203.00 - 269.95
52-Week Range 129.00 - 268.90
Beta n/a
RSI 81.34
Earnings Date n/a

About Accretion Nutraveda

Accretion Nutraveda Limited manufactures and sells ayurvedic and nutraceutical products in India and Internationally. The company specializes in ayurvedic and nutraceutical products including tablets, capsules, oral liquids, oral powders, external preparations, and oils. Its product portfolio includes tablets, such as film-coated and chewable varieties, for applications in liver care, gynecological care, bone and joint health, and respiratory support; capsules, including hard gelatin and HPMC capsules, targeting areas like liver detoxification,... [Read more]

Industry Medicinal Chemicals and Botanical Products
Founded 2021
Country India
Stock Exchange Bombay Stock Exchange
Ticker Symbol 544694
Full Company Profile

Financial Performance

In fiscal year 2025, Accretion Nutraveda's revenue was 160.49 million, an increase of 216.62% compared to the previous year's 50.69 million. Earnings were 26.13 million, an increase of 217.90%.

Financial Statements

News

There is no news available yet.